HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perrigo Expects Trans-Atlantic Boost: Eliminating Irish Tax Debt, Importing European Brands

Executive Summary

In investor conference presentations, CEO Kessler says “we have a very strong case that the way we filed those taxes was correctly and the assessment should be 0,” and bringing its European consumer health brands to the US is “finally starting to really happen.”

You may also be interested in...



Perrigo Paying $309M To Settle $1.9Bn Irish Tax Assessment From Elan Merger

OTC private label/store brand giant announces Irish authorities allow it to pay $308.7m to settle a $1.9bn assessment for back taxes ordered in 2018 linked to Rx ingredient royalty rights it gained in its 2103 merger with Elan.

Perrigo Expects Settlement To Lower Irish Tax Debt

Ireland’s Office of Revenue concluded it “would not object if the Tax Appeals Commission adjusted the amount of the assessment to less than 1 billion,” says Perrigo CEO Murray Kessler.

It’s Official: Perrigo’s Entirely Consumer Health

"We are now a leading pure-play global consumer self-care company that has significant resources to invest,” says CEO Murray Kessler with Rx business sale closing.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS151461

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel